BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19113837)

  • 1. (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor.
    Yin Z; Henry EC; Gasiewicz TA
    Biochemistry; 2009 Jan; 48(2):336-45. PubMed ID: 19113837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein.
    Palermo CM; Westlake CA; Gasiewicz TA
    Biochemistry; 2005 Apr; 44(13):5041-52. PubMed ID: 15794642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.
    Donnelly A; Blagg BS
    Curr Med Chem; 2008; 15(26):2702-17. PubMed ID: 18991631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2.
    Li Y; Zhang T; Jiang Y; Lee HF; Schwartz SJ; Sun D
    Mol Pharm; 2009; 6(4):1152-9. PubMed ID: 19438225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo.
    Tran PL; Kim SA; Choi HS; Yoon JH; Ahn SG
    BMC Cancer; 2010 Jun; 10():276. PubMed ID: 20537126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tetratricopeptide repeat half-site in the aryl hydrocarbon receptor is important for DNA binding and trans-activation potential.
    Levine SL; Petrulis JR; Dubil A; Perdew GH
    Mol Pharmacol; 2000 Dec; 58(6):1517-24. PubMed ID: 11093792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model.
    Moses MA; Henry EC; Ricke WA; Gasiewicz TA
    Cancer Prev Res (Phila); 2015 Mar; 8(3):249-57. PubMed ID: 25604133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transitional States in Ligand-Dependent Transformation of the Aryl Hydrocarbon Receptor into Its DNA-Binding Form.
    Soshilov AA; Motta S; Bonati L; Denison MS
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32252465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the AhR-hsp90-XAP2 core complex and the role of the immunophilin-related protein XAP2 in AhR stabilization.
    Meyer BK; Perdew GH
    Biochemistry; 1999 Jul; 38(28):8907-17. PubMed ID: 10413464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon (Ah) receptor levels are selectively modulated by hsp90-associated immunophilin homolog XAP2.
    Meyer BK; Petrulis JR; Perdew GH
    Cell Stress Chaperones; 2000 Jul; 5(3):243-54. PubMed ID: 11005382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of heat shock protein 90 dissociation in mediating agonist-induced activation of the aryl hydrocarbon receptor.
    Heid SE; Pollenz RS; Swanson HI
    Mol Pharmacol; 2000 Jan; 57(1):82-92. PubMed ID: 10617682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation mechanism of the aryl hydrocarbon receptor (AhR) by molecular chaperone HSP90.
    Tsuji N; Fukuda K; Nagata Y; Okada H; Haga A; Hatakeyama S; Yoshida S; Okamoto T; Hosaka M; Sekine K; Ohtaka K; Yamamoto S; Otaka M; Grave E; Itoh H
    FEBS Open Bio; 2014; 4():796-803. PubMed ID: 25349783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression.
    Williams SN; Shih H; Guenette DK; Brackney W; Denison MS; Pickwell GV; Quattrochi LC
    Chem Biol Interact; 2000 Nov; 128(3):211-29. PubMed ID: 11064004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aryl hydrocarbon (Ah) receptor transcriptional regulator hepatitis B virus X-associated protein 2 antagonizes p23 binding to Ah receptor-Hsp90 complexes and is dispensable for receptor function.
    Hollingshead BD; Petrulis JR; Perdew GH
    J Biol Chem; 2004 Oct; 279(44):45652-61. PubMed ID: 15322122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transactivation domain of the Ah receptor is a key determinant of cellular localization and ligand-independent nucleocytoplasmic shuttling properties.
    Ramadoss P; Perdew GH
    Biochemistry; 2005 Aug; 44(33):11148-59. PubMed ID: 16101299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Per/Arnt/Sim domains in ligand-dependent transformation of the aryl hydrocarbon receptor.
    Soshilov A; Denison MS
    J Biol Chem; 2008 Nov; 283(47):32995-3005. PubMed ID: 18806268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavone antagonists bind competitively with 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation.
    Henry EC; Kende AS; Rucci G; Totleben MJ; Willey JJ; Dertinger SD; Pollenz RS; Jones JP; Gasiewicz TA
    Mol Pharmacol; 1999 Apr; 55(4):716-25. PubMed ID: 10101030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential aryl hydrocarbon receptor antagonists in green tea.
    Palermo CM; Hernando JI; Dertinger SD; Kende AS; Gasiewicz TA
    Chem Res Toxicol; 2003 Jul; 16(7):865-72. PubMed ID: 12870889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand displaces heat shock protein 90 from overlapping binding sites within the aryl hydrocarbon receptor ligand-binding domain.
    Soshilov A; Denison MS
    J Biol Chem; 2011 Oct; 286(40):35275-82. PubMed ID: 21856752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the role for XAP2 in stabilization of the dioxin receptor.
    Lees MJ; Peet DJ; Whitelaw ML
    J Biol Chem; 2003 Sep; 278(38):35878-88. PubMed ID: 12837759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.